Transdermal versus oral granisetron in controlling chemotherapy-induced nausea and vomiting: a meta-analysis.

Alfredo V ChuaAylmer Rex B HernandezIrisyl O Real

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)

Oral granisetron is better in achieving complete control of CINV in patients receiving chemotherapy. As for the risk of constipation and QTc prolongation as adverse effects, there was no statistically significant difference between the two routes.

Keyphrases

chemotherapy induced
drug induced
irritable bowel syndrome
radiation therapy